Mesalamine: Safe at first look [PDF]
L J, Saubermann, J L, Wolf
openaire +2 more sources
Measurement of Colonic Mucosal Concentrations of 5-Aminosalicylic Acid Is Useful for Estimating Its Therapeutic Efficacy in Distal Ulcerative Colitis: Comparison of Orally Administered Mesalamine and Sulfasalazine [PDF]
Makoto Naganuma +8 more
openalex +1 more source
Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine [PDF]
Sreedhar Subramanian +9 more
openalex +1 more source
Mesalamine-induced myopericarditis in children: a case report and a short revision of the literature [PDF]
Mesalamine has a central role in the treatment of inflammatory bowel disease (IBD). Myocarditis and/or pericarditis are rare and severe side effects of mesalamine-containing drugs.
Montanari F. +5 more
core +1 more source
This study evaluates mesalamine-loaded microemulsions designed to enhance drug bioavailability and site-specific delivery in the gastrointestinal (GI) tract, targeting the treatment of Crohn\u27s disease.
Subham Mandal +5 more
core +1 more source
Does Mesalamine Decrease Abdominal Pain in Adults With IBS?
Objective: The objective of this EBM review is to determine whether or not the use of mesalamine decreases abdominal pain in adults with IBS. Study Design: Review of 3 randomized control trials.
Joanis, Ruth
core
Experimental Study on the Treatment of Ulcerative Proctitis in Rats by Combining Baitouweng Decoction with Mesalamine Retention Enema [PDF]
Li Fei +5 more
openalex +1 more source
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence
: Mesalamine-induced lung toxicity has often been described. We report on a case of a patient who underwent mesalamine treatment, though in the absence of established criteria required for diagnosing Crohn's disease (CD) or ulcerative colitis (UC).
Trisolini, R
core +1 more source
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurence
Mesalamine-induced lung toxicity has often been described. We report on a case of a patient who underwent mesalamine treatment, though in the absence of established criteria required for diagnosing Crohn's diseases (CD) or ulcerative colitis (UC).
Trisolini R. +6 more
core

